No Cover Image

Journal article 140 views

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

Afagh Garjani, Rod Middleton Orcid Logo, Rachael Hunter, Katherine A Tuite-Dalton, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen R Pearson, David Rog, Emma C Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou

Multiple Sclerosis and Related Disorders, Volume: 52, Start page: 102939

Swansea University Authors: Rod Middleton Orcid Logo, Rachael Hunter

  • 56804.AAM.pdf

    PDF | Accepted Manuscript

    Distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND) License.

    Download (192.05KB)
Published in: Multiple Sclerosis and Related Disorders
ISSN: 2211-0348
Published: Elsevier BV 2021
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa56804
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: Multiple sclerosis, COVID-19, infection, exacerbation, disease modifying therapies
College: College of Human and Health Sciences
Start Page: 102939